![Tumor Markers - lecture notes - TUMOR MARKERS Ca-19- Normal range 37 U/ml Marker used for the - Studocu Tumor Markers - lecture notes - TUMOR MARKERS Ca-19- Normal range 37 U/ml Marker used for the - Studocu](https://d20ohkaloyme4g.cloudfront.net/img/document_thumbnails/7e49bd12153a725c2e7d929c00543322/thumb_1200_1553.png)
Tumor Markers - lecture notes - TUMOR MARKERS Ca-19- Normal range 37 U/ml Marker used for the - Studocu
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig2_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Table 3 from Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions. | Semantic Scholar Table 3 from Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/58f268adc1826c930e5ed28017498efdd916c6fd/3-Table3-1.png)
Table 3 from Relationships among serum CA15-3 tumor marker, TNM staging, and estrogen and progesterone receptor expression in benign and malignant breast lesions. | Semantic Scholar
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer - ScienceDirect Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419372321-gr2.jpg)